Bruxism
121
11
13
67
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Research Maturity
67 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.5%
3 terminated out of 121 trials
95.7%
+9.1% vs benchmark
4%
5 trials in Phase 3/4
4%
3 of 67 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 67 completed trials
Clinical Trials (121)
Botulinum Toxin-A for Bruxism Using Digital Occlusal Analysis
Efficacy and Safety of HA35 Gel Nighttime Occlusive Application for TMD Pain
Synchronous vs Asynchronous Telerehabilitation for Bruxism
Biochemical Factors in Patients With and Without Bruxism
Short-Term Symptom Changes in Adults With Teeth Clenching or Grinding and Jaw Symptoms Receiving Splint, Botulinum Toxin, or Medication Plus Splint Care
Botulinum Toxin Type A Versus Oral Ibuprofen for Bruxism
The Effect of Bruxism on Balance
Effects of Different Graston Technique Application Speeds on Trapezius Muscle Stiffness, Pressure Pain Threshold, Pain, and Muscle Oxygenation in Patients With Bruxism
Effects of Cervical and Sacroiliac Mobilization Combined With Pilates on Bruxism
Evaluation of Salivary Biomarkers in Individuals With Bruxism
Effect of Marjoram, Vetiver, and Lavender Oil in the Treatment of Bruxism
Vertical Facial Morphology and Occlusal Force Changes After Masseter Botulinum Toxin Injection in Bruxism
Temporomandibular Disorders and Bruxism in Elite Basketball Referees
Bruxism Therapy of Facial Pain
Impact of Distress Level, Sleep Quality and Occlusal Trauma on Periodontal Status Among Bruxers
Psychological Resilience, Perceived Stress and Periodontal Status Among Bruxers
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
Chewing Muscles in Bruxers
Bruxism, Anxiety, and Periodontal Status Among Dental Students
Impact of Subgingival Instrumentation on Jaw Symptoms of Probable Bruxers Among Patients With Periodontitis